<?xml version="1.0" encoding="UTF-8"?>
 <rdf:RDF
 xmlns="http://purl.org/rss/1.0/"
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:dcterms="http://purl.org/dc/terms/"
 xmlns:admin="http://webns.net/mvcb/"
 xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://prismstandard.org/namespaces/2.0/basic/"
 xmlns:foaf="http://xmlns.com/foaf/0.1/">
 <channel rdf:about="http://api.ingentaconnect.com/content/pal/jcb/latest?format=rss">
 <title>Latest Issue of JOURNAL OF COMMERCIAL BIOTECHNOLOGY</title>
 <link>https://www.ingentaconnect.com/content/pal/jcb/latest</link>
 <description>RSS feed of the most recently published issue of JOURNAL OF COMMERCIAL BIOTECHNOLOGY</description>
 <image rdf:resource="https://www.ingentaconnect.com/journal-logos/pal/jcb.gif"/>
 <dc:description>RSS feed of the most recently published issue of JOURNAL OF COMMERCIAL BIOTECHNOLOGY</dc:description>
 <dc:title>Latest Issue of JOURNAL OF COMMERCIAL BIOTECHNOLOGY RSS Feed</dc:title>
 <dc:date>2018-03-02T03:12:26Z</dc:date>
 <admin:generatorAgent rdf:resource="https://www.ingentaconnect.com"/>
 <admin:errorReportsTo rdf:resource="mailto:help@ingentaconnect.com"/>
 <sy:updatePeriod>daily</sy:updatePeriod>
 <sy:updateFrequency>2</sy:updateFrequency>
 <sy:updateBase>2004-01-01T07:00+00:00</sy:updateBase>
 <items>
 <rdf:Seq>
 <rdf:li rdf:resource="https://www.ingentaconnect.com/content/pal/jcb/2011/00000017/00000004/art00001"/>
 <rdf:li rdf:resource="https://www.ingentaconnect.com/content/pal/jcb/2011/00000017/00000004/art00002"/>
 <rdf:li rdf:resource="https://www.ingentaconnect.com/content/pal/jcb/2011/00000017/00000004/art00003"/>
 <rdf:li rdf:resource="https://www.ingentaconnect.com/content/pal/jcb/2011/00000017/00000004/art00004"/>
 <rdf:li rdf:resource="https://www.ingentaconnect.com/content/pal/jcb/2011/00000017/00000004/art00005"/>
 <rdf:li rdf:resource="https://www.ingentaconnect.com/content/pal/jcb/2011/00000017/00000004/art00006"/>
 <rdf:li rdf:resource="https://www.ingentaconnect.com/content/pal/jcb/2011/00000017/00000004/art00007"/>
 <rdf:li rdf:resource="https://www.ingentaconnect.com/content/pal/jcb/2011/00000017/00000004/art00008"/>
 <rdf:li rdf:resource="https://www.ingentaconnect.com/content/pal/jcb/2011/00000017/00000004/art00009"/>
 <rdf:li rdf:resource="https://www.ingentaconnect.com/content/pal/jcb/2011/00000017/00000004/art00010"/>
 </rdf:Seq>
 </items>
<dc:publisher>Palgrave Macmillan</dc:publisher>
<dc:rights>(copyright) 2018 Palgrave Macmillan</dc:rights>
<prism:publicationName>JOURNAL OF COMMERCIAL BIOTECHNOLOGY</prism:publicationName>
<prism:distributor>Ingenta Connect</prism:distributor>
<prism:coverDisplayDate>1 November 2011</prism:coverDisplayDate>
<prism:isPartOf rdf:resource="urn:issn:1462-8732"/><prism:issn>1462-8732</prism:issn>
 </channel>
<item rdf:about="https://www.ingentaconnect.com/content/pal/jcb/2011/00000017/00000004/art00001">
<link>https://www.ingentaconnect.com/content/pal/jcb/2011/00000017/00000004/art00001</link>
<title>Exciting changes</title>
<dc:title>Exciting changes</dc:title>
<dc:format>application/pdf</dc:format>
<dc:creator>Friedman, Yali</dc:creator>
<foaf:maker><foaf:Person><foaf:givenName>Yali</foaf:givenName><foaf:familyName>Friedman</foaf:familyName><foaf:name>Friedman, Yali</foaf:name></foaf:Person></foaf:maker>
<prism:volume>17</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>289</prism:startingPage><prism:endingPage>289</prism:endingPage>
<prism:isPartOf rdf:resource="https://www.ingentaconnect.com/content/pal/jcb/2011/00000017/00000004"/>
</item>
<item rdf:about="https://www.ingentaconnect.com/content/pal/jcb/2011/00000017/00000004/art00002">
<link>https://www.ingentaconnect.com/content/pal/jcb/2011/00000017/00000004/art00002</link>
<title>New technologies for neglected diseases: Can tax credits help biotechnology companies advance global health?</title>
<dc:title>New technologies for neglected diseases: Can tax credits help biotechnology companies advance global health?</dc:title>
<dc:format>application/pdf</dc:format>
<dc:creator>Rao, Aarthi</dc:creator>
<foaf:maker><foaf:Person><foaf:givenName>Aarthi</foaf:givenName><foaf:familyName>Rao</foaf:familyName><foaf:name>Rao, Aarthi</foaf:name></foaf:Person></foaf:maker>
<prism:volume>17</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>290</prism:startingPage><prism:endingPage>292</prism:endingPage>
<prism:isPartOf rdf:resource="https://www.ingentaconnect.com/content/pal/jcb/2011/00000017/00000004"/>
</item>
<item rdf:about="https://www.ingentaconnect.com/content/pal/jcb/2011/00000017/00000004/art00003">
<link>https://www.ingentaconnect.com/content/pal/jcb/2011/00000017/00000004/art00003</link>
<title>Biotechnology commercialisation in universities of developing countries: A review of the University of Ibadan, Nigeria</title>
<dc:title>Biotechnology commercialisation in universities of developing countries: A review of the University of Ibadan, Nigeria</dc:title>
<dc:format>application/pdf</dc:format>
<dc:creator>Onyeka, Chimdiya Julian</dc:creator>
<foaf:maker><foaf:Person><foaf:givenName>Chimdiya Julian</foaf:givenName><foaf:familyName>Onyeka</foaf:familyName><foaf:name>Onyeka, Chimdiya Julian</foaf:name></foaf:Person></foaf:maker>
<prism:volume>17</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>293</prism:startingPage><prism:endingPage>300</prism:endingPage>
<prism:isPartOf rdf:resource="https://www.ingentaconnect.com/content/pal/jcb/2011/00000017/00000004"/>
</item>
<item rdf:about="https://www.ingentaconnect.com/content/pal/jcb/2011/00000017/00000004/art00004">
<link>https://www.ingentaconnect.com/content/pal/jcb/2011/00000017/00000004/art00004</link>
<title>Innovation in R&amp;D: Using design thinking to develop new models of inventiveness, productivity and collaboration</title>
<dc:title>Innovation in R&amp;D: Using design thinking to develop new models of inventiveness, productivity and collaboration</dc:title>
<dc:format>application/pdf</dc:format>
<dc:creator>Simons, Tad</dc:creator><dc:creator>Gupta, Arvind</dc:creator><dc:creator>Buchanan, Mary</dc:creator>
<foaf:maker><foaf:Person><foaf:givenName>Tad</foaf:givenName><foaf:familyName>Simons</foaf:familyName><foaf:name>Simons, Tad</foaf:name></foaf:Person></foaf:maker><foaf:maker><foaf:Person><foaf:givenName>Arvind</foaf:givenName><foaf:familyName>Gupta</foaf:familyName><foaf:name>Gupta, Arvind</foaf:name></foaf:Person></foaf:maker><foaf:maker><foaf:Person><foaf:givenName>Mary</foaf:givenName><foaf:familyName>Buchanan</foaf:familyName><foaf:name>Buchanan, Mary</foaf:name></foaf:Person></foaf:maker>
<prism:volume>17</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>301</prism:startingPage><prism:endingPage>307</prism:endingPage>
<prism:isPartOf rdf:resource="https://www.ingentaconnect.com/content/pal/jcb/2011/00000017/00000004"/>
</item>
<item rdf:about="https://www.ingentaconnect.com/content/pal/jcb/2011/00000017/00000004/art00005">
<link>https://www.ingentaconnect.com/content/pal/jcb/2011/00000017/00000004/art00005</link>
<title>The strength of pharmaceutical IPRs vis-à-vis foreign direct investment in clinical research: Preliminary findings</title>
<dc:title>The strength of pharmaceutical IPRs vis-à-vis foreign direct investment in clinical research: Preliminary findings</dc:title>
<dc:format>application/pdf</dc:format>
<dc:creator>Pugatch, Meir Perez</dc:creator><dc:creator>Chu, Rachel</dc:creator>
<foaf:maker><foaf:Person><foaf:givenName>Meir Perez</foaf:givenName><foaf:familyName>Pugatch</foaf:familyName><foaf:name>Pugatch, Meir Perez</foaf:name></foaf:Person></foaf:maker><foaf:maker><foaf:Person><foaf:givenName>Rachel</foaf:givenName><foaf:familyName>Chu</foaf:familyName><foaf:name>Chu, Rachel</foaf:name></foaf:Person></foaf:maker>
<prism:volume>17</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>308</prism:startingPage><prism:endingPage>318</prism:endingPage>
<prism:isPartOf rdf:resource="https://www.ingentaconnect.com/content/pal/jcb/2011/00000017/00000004"/>
</item>
<item rdf:about="https://www.ingentaconnect.com/content/pal/jcb/2011/00000017/00000004/art00006">
<link>https://www.ingentaconnect.com/content/pal/jcb/2011/00000017/00000004/art00006</link>
<title>Some considerations for the implementation of disposable technology and single-use systems in biopharmaceuticals</title>
<dc:title>Some considerations for the implementation of disposable technology and single-use systems in biopharmaceuticals</dc:title>
<dc:format>application/pdf</dc:format>
<dc:creator>Sandle, Tim</dc:creator><dc:creator>Saghee, Madhu Raju</dc:creator>
<foaf:maker><foaf:Person><foaf:givenName>Tim</foaf:givenName><foaf:familyName>Sandle</foaf:familyName><foaf:name>Sandle, Tim</foaf:name></foaf:Person></foaf:maker><foaf:maker><foaf:Person><foaf:givenName>Madhu Raju</foaf:givenName><foaf:familyName>Saghee</foaf:familyName><foaf:name>Saghee, Madhu Raju</foaf:name></foaf:Person></foaf:maker>
<prism:volume>17</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>319</prism:startingPage><prism:endingPage>329</prism:endingPage>
<prism:isPartOf rdf:resource="https://www.ingentaconnect.com/content/pal/jcb/2011/00000017/00000004"/>
</item>
<item rdf:about="https://www.ingentaconnect.com/content/pal/jcb/2011/00000017/00000004/art00007">
<link>https://www.ingentaconnect.com/content/pal/jcb/2011/00000017/00000004/art00007</link>
<title>Catalyzing capital for Canada&#039;s life sciences industry</title>
<dc:title>Catalyzing capital for Canada&#039;s life sciences industry</dc:title>
<dc:format>application/pdf</dc:format>
<dc:creator>Tucker, Joseph</dc:creator><dc:creator>Chakma, Justin</dc:creator><dc:creator>Fedak, Paul WM</dc:creator><dc:creator>Cimini, Massimo</dc:creator>
<foaf:maker><foaf:Person><foaf:givenName>Joseph</foaf:givenName><foaf:familyName>Tucker</foaf:familyName><foaf:name>Tucker, Joseph</foaf:name></foaf:Person></foaf:maker><foaf:maker><foaf:Person><foaf:givenName>Justin</foaf:givenName><foaf:familyName>Chakma</foaf:familyName><foaf:name>Chakma, Justin</foaf:name></foaf:Person></foaf:maker><foaf:maker><foaf:Person><foaf:givenName>Paul WM</foaf:givenName><foaf:familyName>Fedak</foaf:familyName><foaf:name>Fedak, Paul WM</foaf:name></foaf:Person></foaf:maker><foaf:maker><foaf:Person><foaf:givenName>Massimo</foaf:givenName><foaf:familyName>Cimini</foaf:familyName><foaf:name>Cimini, Massimo</foaf:name></foaf:Person></foaf:maker>
<prism:volume>17</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>330</prism:startingPage><prism:endingPage>348</prism:endingPage>
<prism:isPartOf rdf:resource="https://www.ingentaconnect.com/content/pal/jcb/2011/00000017/00000004"/>
</item>
<item rdf:about="https://www.ingentaconnect.com/content/pal/jcb/2011/00000017/00000004/art00008">
<link>https://www.ingentaconnect.com/content/pal/jcb/2011/00000017/00000004/art00008</link>
<title>Academic entrepreneurship, entrepreneurial universities and biotechnology</title>
<dc:title>Academic entrepreneurship, entrepreneurial universities and biotechnology</dc:title>
<dc:format>application/pdf</dc:format>
<dc:creator>Meyers, Arlen D</dc:creator><dc:creator>Pruthi, Sarika</dc:creator>
<foaf:maker><foaf:Person><foaf:givenName>Arlen D</foaf:givenName><foaf:familyName>Meyers</foaf:familyName><foaf:name>Meyers, Arlen D</foaf:name></foaf:Person></foaf:maker><foaf:maker><foaf:Person><foaf:givenName>Sarika</foaf:givenName><foaf:familyName>Pruthi</foaf:familyName><foaf:name>Pruthi, Sarika</foaf:name></foaf:Person></foaf:maker>
<prism:volume>17</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>349</prism:startingPage><prism:endingPage>357</prism:endingPage>
<prism:isPartOf rdf:resource="https://www.ingentaconnect.com/content/pal/jcb/2011/00000017/00000004"/>
</item>
<item rdf:about="https://www.ingentaconnect.com/content/pal/jcb/2011/00000017/00000004/art00009">
<link>https://www.ingentaconnect.com/content/pal/jcb/2011/00000017/00000004/art00009</link>
<title>Patent strategies for life sciences companies to navigate the changing patent landscape</title>
<dc:title>Patent strategies for life sciences companies to navigate the changing patent landscape</dc:title>
<dc:format>application/pdf</dc:format>
<dc:creator>Dykeman, David J</dc:creator><dc:creator>Abramson, Danielle T</dc:creator>
<foaf:maker><foaf:Person><foaf:givenName>David J</foaf:givenName><foaf:familyName>Dykeman</foaf:familyName><foaf:name>Dykeman, David J</foaf:name></foaf:Person></foaf:maker><foaf:maker><foaf:Person><foaf:givenName>Danielle T</foaf:givenName><foaf:familyName>Abramson</foaf:familyName><foaf:name>Abramson, Danielle T</foaf:name></foaf:Person></foaf:maker>
<prism:volume>17</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>358</prism:startingPage><prism:endingPage>364</prism:endingPage>
<prism:isPartOf rdf:resource="https://www.ingentaconnect.com/content/pal/jcb/2011/00000017/00000004"/>
</item>
<item rdf:about="https://www.ingentaconnect.com/content/pal/jcb/2011/00000017/00000004/art00010">
<link>https://www.ingentaconnect.com/content/pal/jcb/2011/00000017/00000004/art00010</link>
<title>FDA at BIO 2011 &amp;#8211; Weighing a hefty mission: Where is the balance?</title>
<dc:title>FDA at BIO 2011 &amp;#8211; Weighing a hefty mission: Where is the balance?</dc:title>
<dc:format>application/pdf</dc:format>
<dc:creator>Levy, Suzanne</dc:creator>
<foaf:maker><foaf:Person><foaf:givenName>Suzanne</foaf:givenName><foaf:familyName>Levy</foaf:familyName><foaf:name>Levy, Suzanne</foaf:name></foaf:Person></foaf:maker>
<prism:volume>17</prism:volume>
<prism:number>4</prism:number>
<prism:startingPage>365</prism:startingPage><prism:endingPage>366</prism:endingPage>
<prism:isPartOf rdf:resource="https://www.ingentaconnect.com/content/pal/jcb/2011/00000017/00000004"/>
</item>
 </rdf:RDF>
